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Dual role for the RNA-binding domain of Xenopus
laevis SLBP1 in histone pre-mRNA processing
THOMAS C. INGLEDUE III, ZBIGNIEW DOMINSKI, RICARDO SÁNCHEZ,
JUDITH A. ERKMANN, and WILLIAM F. MARZLUFF
Department of Biochemistry and Biophysics, Program in Molecular Biology and Biotechnology,
University of North Carolina, Chapel Hill, North Carolina 27599, USA
ABSTRACT
The replication-dependent histone mRNAs end in a conserved 26-nt sequence that forms a stem-loop structure. This
sequence is required for histone pre-mRNA processing and plays a role in multiple aspects of histone mRNA me-
tabolism. Two proteins that bind the 3 9 end of histone mRNA are found in Xenopus oocytes. xSLBP1 is found in the
nucleus, where it functions in histone pre-mRNA processing, and in the cytoplasm, where it may control histone
mRNA translation and stability. xSLBP2 is a cytoplasmic protein, inactive in histone pre-mRNA processing, whose
expression is restricted to oogenesis and early development. These proteins are similar only in their RNA-binding
domains (RBD). A chimeric protein (1-2-1) in which the RBD of xSLBP1 has been replaced with the RBD of xSLBP2
binds the stem-loop with an affinity similar to the original protein. The 1-2-1 protein efficiently localizes to the nucleus
of the frog oocyte, but is not active in processing of histone pre-mRNA in vivo. This protein does not support
processing in a nuclear extract, but inhibits processing by competing with the active SLBP by binding to the sub-
strate. The 1-2-1 protein also inhibits processing of synthetic histone pre-mRNA injected into frog oocytes, but has
no effect on processing of histone pre-mRNA transcribed from an injected histone gene. This result suggests that
sequences in the RBD of xSLBP1 give it preferential access to histone pre-mRNA transcribed in vivo.
Keywords: 3 9 processing; histone mRNA; Xenopus oocyte
INTRODUCTION
Replication-dependent histone mRNAs are not poly-
adenylated; they end in a highly conserved 26-nt se-
quence containing a 16-nt stem-loop (Marzluff, 1992;
Dominski & Marzluff, 1999)+ Histone pre-mRNAs do
not contain introns, and only a single endonucleolytic
cleavage to form the 39 end (Gick et al+, 1986) is nec-
essary to generate a mature histone mRNA+ This cleav-
age requires two cis-acting sequences in the histone
pre-mRNA: the stem-loop and a purine-rich histone
downstream element (HDE), which is located approx-
imately 10 nt past the cleavage site+ These elements
are recognized by two trans-acting factors: the stem-
loop binding protein (SLBP) (Wang et al+, 1996c;Martin
et al+, 1997) and the U7 snRNP+ The 59 end of U7
snRNA base pairs with the HDE (Mowry & Steitz, 1987;
Cotten et al+, 1988; Soldati & Schümperli, 1988)+ Addi-
tional factor(s) that have not been well characterized,
including a heat-labile factor (Gick et al+, 1987), are
also required+ One role of the SLBP in the processing
reaction is stabilization of binding of the U7 snRNP to
the histone pre-mRNA (Spycher et al+, 1994; Dominski
et al+, 1999), resulting in a stable complex containing
histone pre-mRNA, SLBP, and U7 snRNP+
In mammalian cells, SLBP functions in the process-
ing reaction in the nucleus and accompanies the his-
tone mRNA to the cytoplasm, where it remains with the
mRNA on polyribosomes as a component of the his-
tone mRNP (Hanson et al+, 1996)+ Recently we have
cloned two SLBPs from frog oocytes (Wang et al+, 1999)+
xSLBP1 is the homolog of the mammalian SLBP and is
involved in histone pre-mRNA processing+ The other
protein, xSLBP2, is cytoplasmic and bound to histone
mRNA in the frog oocyte+ During oocyte maturation,
xSLBP2 is destroyed and histone mRNA associates
with xSLBP1 (Wang et al+, 1999)+ These two SLBPs
are similar only in their 73 amino acid RNA-binding
domains (RBD) located in the center of each protein
(Wang et al+, 1999)+
The availability of two SLBPs that bind the same
RNA target has allowed us to construct and express
chimeric proteins that retain the same RNA-binding
specificity+ Using complementation assays for histone
pre-mRNA processing, we show that substitution of the
RBD of xSLBP2 for the RBD of xSLBP1 results in a
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chimeric protein, 1-2-1, that does not function in pro-
cessing in vivo or in vitro+
RESULTS
The 39 end of histone mRNA and its bound SLBP play
a critical role in multiple aspects of histone mRNA me-
tabolism, including pre-mRNA processing (Dominski
et al+, 1995; Wang et al+, 1996c; Martin et al+, 1997),
export (Eckner et al+, 1991;Williams et al+, 1994), trans-
lation (Sun et al+, 1992; Gallie et al+, 1996), and mRNA
stability (Pandey & Marzluff, 1987;Williams et al+, 1994)+
The frog oocyte is a convenient experimental system
to study the many aspects of RNA metabolism be-
cause one can express or inject both specific RNAs
and proteins and follow their subsequent metabolism+
Measurement of processing efficiency
in Xenopus oocytes
When the mouse histone H2a-614 gene is injected into
frog oocyte nuclei, properly processed histone mRNA
is produced and the mature histone mRNA is efficiently
transported to the cytoplasm (Williams et al+, 1994)+
We developed an assay that detects both processed
and unprocessed histone mRNAs generated from the
injected mouse H2a-614 gene (Wang et al+, 1999), al-
lowing us to determine the efficiency of histone pre-
mRNA processing in vivo (Fig+ 1A)+ The 260-nt probe
detects processed histone H2a-614 mRNA as a 183-nt
fragment+ Any unprocessed histone mRNAs (which
would be expected to have heterogeneous 39 ends) will
protect a 217-nt fragment (Fig+ 1A)+ Because the probe
and each protected fragment has a single radioactive
phosphate, the efficiency of processing can be deter-
mined by comparing the intensity of the two protected
fragments+ Plasmid DNA that is injected into the oocyte
cytoplasm is not transcribed, so the results are not
affected by the efficiency of injecting the DNA into the
nucleus+
The efficiency of histone pre-mRNA processing from
an injected gene was dependent on the amount of DNA
injected (and hence the amount of pre-mRNA synthe-
sized)+ When small amounts of DNA (150 pg) were
injected, we often observed nearly 100% processing;
larger amounts of injected DNA lowered processing
efficiencies, as some of the factors for processing be-
came limiting with the increase in rate of production of
histone pre-mRNA+ We chose a DNA amount (450 pg)
that gave processing efficiencies between 20 and 80%,
depending on the batch of oocytes+
Unprocessed histone mRNA is stable
in Xenopus oocytes
For this assay to be a valid estimate of the efficiency of
histone pre-mRNA processing, it is necessary that the
unprocessed pre-mRNA not be rapidly degraded+ In
somatic mammalian cultured cells, unprocessed his-
tone pre-mRNA is virtually undetectable (Stauber &
Schümperli, 1988; Pandey et al+, 1994)+ This is due
both to the rapid processing of the histone pre-mRNA
in vivo and the rapid degradation of any unprocessed
pre-mRNA in the nucleus (Pandey et al+, 1994)+ In
contrast, unprocessed histone pre-mRNA is easily de-
tectable in Xenopus oocytes (Williams et al+, 1994), as
are unprocessed or prematurely terminated transcripts
(Bentley & Groudine, 1988; Bentley et al+, 1989;Middle-
ton & Morgan, 1990) from other genes+ Thus it is likely
that most RNAs, including histone pre-mRNA, are rel-
atively stable in oocytes, unlike the situation in cultured
cells+
To demonstrate the stability of histone pre-mRNA in
oocytes, we did two different experiments+ We carried
out chase experiments and also expressed an uncleav-
able histone pre-mRNA in oocytes+ In these experi-
ments the oocytes were injected with blue Dextran,
which remains in the nucleus, together with the DNA+
Because only oocytes that were successfully injected
in the nucleus were analyzed, we can make quantita-
tive comparisons between samples+Oocytes from each
female processed histone pre-mRNA to a different ex-
tent, and in each experiment the H2a-614 gene was
injected as a control+ Thus the oocytes used in Fig-
ure 1B and in lanes 3 and 4 of Figure 1C processed the
H2a-614 pre-mRNA with over 90% efficiency, whereas
the oocytes used in Figure 1C, lanes 1 and 2 only
processed the H2a-614 pre-mRNA with 60% efficiency+
Actinomycin D (200 mg/mL in the media) completely
blocked expression of histone RNA in Xenopus oo-
cytes (Fig+ 1B), whereas another inhibitor of RNA poly-
merase II transcription,DRB, reduced but did not abolish
transcription of the histone gene (not shown)+ The H2a-
614 gene was injected into the oocyte nucleus and the
oocytes incubated for 18 h, during which time the his-
tone genes were transcribed and about 60% of the
histone pre-mRNA was processed (Fig+ 1C, lane 1)+
RNA was prepared from half of the oocytes and the
other half of the oocytes were incubated with Actino-
mycin D to block further transcription during a 5-h
“chase” period+ During the chase in the absence of
transcription almost all of the remaining histone pre-
mRNA was processed (Fig+ 1C, lane 2), demonstrating
that the pre-mRNA was sufficiently stable to allow sub-
sequent processing+ This result also demonstrates that
histone pre-mRNA processing does not require ongo-
ing transcription, and that the processed histone mRNA
is stable+ As determined by PhosphorImager analysis,
the total amount of histone mRNA was essentially iden-
tical in the two samples+
To definitively demonstrate that histone pre-mRNAs
were stable, we expressed a mutant histone pre-
mRNA (H2a-4G) that is resistant to processing be-
cause it has Gs substituted at the cleavage site
1636 T.C. Ingledue III et al.
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(Dominski et al+, 1999)+ Histone pre-mRNAs expressed
from this gene were not processed and the unpro-
cessed pre-mRNA accumulated to high levels (Fig+ 1C,
lane 4)+ In a parallel batch of oocytes injected with
the H2a-614 gene, more than 90% of the wild-type
histone pre-mRNA was processed (Fig+ 1C, lane 3)+
The amount of the histone pre-mRNA that accumu-
lated from the H2a-4G gene was similar to the amount
of processed mRNA accumulated from the H2a-614
gene (Fig+ 1C, lanes 3 and 4)+ We conclude that the
histone pre-mRNA is stable in the oocyte and that
changes observed in the ratio of histone mRNA to
histone pre-mRNA reflect differences in the efficiency






FIGURE 1. Characterization of the processing of histone pre-mRNA derived from injected DNA+ A: The S1 nuclease
protection assay used to measure histone pre-mRNA processing is diagramed+ The 260-nt probe contains 43 nt that are not
present in the H2a-614 histone pre-mRNA, but are derived from the vector pBluescript KS (zig-zag line)+ The unprocessed
RNAs protect a 217-nt fragment regardless of their 39 end and the processed histone mRNAs protect a 183-nt fragment+
Because the probe is 39-end labeled, the ratio of the intensity of the two fragments is a measure of processing efficiency+
B: Frog oocytes were preincubated in buffer (lane 2) or with 200 mg/mL Actinomycin D (lane 3) for 1 h+ They were then
injected with the histone H2a-614 gene and blue Dextran, and incubated in the continued presence of the inhibitor for 18 h+
RNA was prepared and then assayed for histone H2a-614 mRNA+ Lane 1 is marker pUC18 digested with MspI+ C: Oocytes
were injected with the H2a-614 gene and blue Dextran, incubated for 18 h and then half of the oocytes were harvested
(lane 1) and the other half were incubated for an additional 5 h in 200 mg/mL Actinomycin D (lane 2)+ A separate batch of
oocytes was injected with either the H2a-614 gene (lane 3) or with the histone H2a-4G gene (lane 4) and incubated for 18 h+
The H2a-4G gene produces a transcript that cannot be processed because of the insertion of four Gs at the cleavage site
(Dominski et al+, 1999)+ RNA was prepared from the oocytes and RNA from the equivalent of one oocyte analyzed by S1
nuclease mapping+ D: Frog oocytes were injected with the histone H2a-614 gene and the levels of processed and unpro-
cessed histone mRNAs measured 18 h later (lane 1)+ In lane 2, the human U7 gene (Jacobs et al+, 1999) was coinjected
into the nucleus with the H2a-614 gene+ In lane 3 the oocytes were injected with synthetic xSLBP1 mRNA 30 h prior to
injection of the histone H2a-614 gene+ In lane 4, the oocytes were injected with the xSLBP1 mRNA 30 h prior to coinjection
of the human U7 gene and the histone H2a-614 gene+ The processing efficiency (percent processing) quantified using a
PhosphorImager is indicated below each lane+
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xSLBP1 and U7 snRNP cooperate to process
histone pre-mRNA in vivo
Histone pre-mRNA processing in oocytes requires both
xSLBP1 (Wang et al+, 1999) and the U7 snRNP (Scharl
& Steitz, 1996) as well as other factors+A critical step in
vitro is assembly of a stable complex containing SLBP
and U7 snRNA on the histone pre-mRNA (Dominski
et al+, 1999), and efficient assembly of the complex
requires both stable binding (high affinity) of SLBP to
the stem-loop and base-pairing of U7 snRNP to the
pre-mRNA (Dominski et al+, 1999)+To determine whether
xSLBP1 or U7 snRNP were limiting for processing in
vivo we increased the concentration of U7 snRNA by
expressing U7 snRNA from the human U7 snRNA gene
(Jacobs et al+, 1999) and the concentrations of xSLBP1
by injecting synthetic xSLBP1 mRNA+ There are ex-
cess snRNP proteins present in the frog oocyte that
will assemble U7 snRNA into functional U7 snRNP par-
ticles (Strub & Birnstiel, 1986)+ In this experiment we
used a batch of oocytes that processed the histone
H2a-614 mRNA relatively inefficiently (Fig+ 1D, lane 1)+
Overexpression of either U7 snRNA or xSLBP1 re-
sulted in an increased efficiency of processing (Fig+ 1D,
lanes 2 and 3)+ Overexpression of both xSLBP1 and
U7 snRNA in the same oocytes resulted in a further
increase in processing (Fig+ 1D, lane 4)+ Thus both U7
snRNP and xSLBP1 are present at suboptimal concen-
trations for processing the histone H2a-614 pre-mRNA
expressed in the oocyte+ This result is consistent with
the suggestion that these two factors cooperate in his-
tone pre-mRNA processing (Melin et al+, 1992; Streit
et al+, 1993; Dominski et al+, 1999)+
Structure of xSLBP chimeras
The xSLBP1 and xSLBP2 proteins were divided into
three domains, based on the definition of the 73 amino
acids in the center of the protein as an RNA-binding
domain (Wang et al+, 1996c)+We use the term RBD for
the RNA-binding domain; this term simply reflects the
ability of the 73-amino acid domain to bind RNA and is
not meant to imply any similarity in structure to other
RNA-binding proteins+ This 73-amino acid region binds
the stem-loop with an affinity similar to full-length SLBP
(Wang et al+, 1996c)+ The amino terminal and the car-
boxyl terminal regions were arbitrarily designated as
other domains of the SLBPs+ The amino acid sequences
of the RBD of xSLBP1 and xSLBP2 are compared in
Figure 2A+ The terminal amino acids at each end of the
RBD are conserved in both Xenopus SLBPs and in the
mammalian SLBP+ Only minimal changes were intro-
duced at the amino terminal boundary of the domain
during construction of the various chimeric proteins
(Fig+ 2B,C)+
Each construct was transcribed with SP6 RNA poly-
merase to produce a synthetic capped polyadenylated
mRNA that was injected into stage VI oocytes+ Expres-
sion of the protein product was detected by its ability to
bind a radiolabeled histone mRNA stem-loop (Williams
& Marzluff, 1995)+ The oocytes were subsequently in-
jected with the mouse histone H2a-614 gene and the
ability of the protein(s) to affect histone pre-mRNA pro-
cessing determined+
The xSLBP2 RBD cannot substitute
for the xSLBP1 RBD in vivo
The RBD of SLBP1 and SLBP2 are 70% identical and
bind the stem-loop with similar affinity (Wang et al+,
1999)+ To determine if the only role of the RBD in his-
tone pre-mRNA processing was to bind the protein to
the pre-mRNA, we tested the ability of the chimeric
1-2-1 SLBP to complement processing+ The same batch
of oocytes was injected with a control solution or mRNAs





FIGURE 2. Chimeric clones of the SLBPs+ A: The amino acid se-
quence of the RBDs of xSLBP1 and xSLBP2 is shown+ The numbers
indicate the position of each region in the amino acid sequence of
the protein and the differences between the RBD of xSLBP1 and
xSLBP2 are indicated in bold+ B: The amino acid sequence imme-
diately flanking the RBD of xSLBP1 and xSLBP2 is shown+ The
amino acid sequences at the junctions of chimeric SLBP clones are
shown (the RBD is in bold)+ The same sequences are found in all the
chimeric clones at the junctions of the SLBP1 and SLBP2 domains+
C: The chimeric SLBPs, constructed from the three domains from
xSLBP1 and xSLBP2, and the deletion clone 0-1-(1/2) used in this
study are diagramed+
1638 T.C. Ingledue III et al.
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opus hnRNP A1 (as a control RNA binding protein), or
1-2-1+ About 30% of the histone H2a-614 pre-mRNA
was processed in this batch of oocytes (Fig+ 3A, lane 2)+
Overexpression of xSLBP1 increased processing to
.85% (Fig+ 3A, lane 4), whereas expression of hnRNP
A1 had no effect on processing (Fig+ 3A, lane 3)+ Ex-
pression of 1-2-1 also had little effect on processing
(Fig+ 3A, lane 5)+ Similar results were obtained with
oocytes from a different frog,where we injected xSLBP2
mRNA as well as xSLBP1 or 1-2-1 mRNAs+ Again ex-
pression of xSLBP1 increased processing efficiency to
.85% (Fig+ 3B, lane 3), whereas expression of 1-2-1
(Fig+ 3B, lane 4), or xSLBP2 (Fig+ 3B, lane 2) did not
have a significant effect on processing+
Because histone pre-mRNA processing occurs in the
nucleus, we tested the ability of 1-2-1 to efficiently lo-
calize to the nucleus+ The injection of synthetic mRNA
encoding the various SLBPs resulted in at least a 10–
20-fold increase in active (based on RNA binding) SLBP
in the frog oocytes (Wang et al+, 1999; see Fig+ 4C,
lanes 2–3 and 9–10)+ Synthetic mRNA encoding the
relevant clone was injected into oocytes+ Two days later,
oocytes were fractionated into nuclear and cytoplas-
mic components and the fractions assayed by the mo-
bility shift assay+ As we have previously shown (Wang
et al+, 1999), overexpressed SLBP1 is found in both the
nucleus and the cytoplasm in similar proportions as the
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FIGURE 3. The xSLBP2 RNA binding domain does not function in histone pre-mRNA processing in vivo+ A,B: Xenopus
oocytes were injected with synthetic mRNAs encoding the indicated RNA-binding proteins+ Forty-eight hours later the
oocyte nuclei were injected with a plasmid encoding the mouse histone H2a-614 gene+ Eighteen hours later RNA was
prepared and assayed for processed (Proc) and unprocessed (Unproc) mouse histone H2a-614 mRNA using the S1
nuclease assay diagramed in Figure 1A+ Lane labeled M is pUC18 DNA digested with MspI+ The results are representative
of at least three independent experiments with each construct+ A: Oocytes were injected with buffer (lane 2), synthetic
mRNA encoding Xenopus HnRNP A1 (lane 3), xSLBP1 (lane 4), or the 1-2-1 chimeric protein (lane 5)+ The percent
processing determined using a PhosphorImager is indicated below each lane+ B: Oocytes were injected with buffer (lane 1),
synthetic mRNA encoding xSLBP2 (lane 2), xSLBP1 (lane 3), or the chimeric protein 1-2-1 (lane 4) and assayed for the
processing of the H2a-614 pre-mRNA+ The processing efficiency (percent processing) quantified using a PhosphorImager
is indicated below each lane+ C: Oocytes were injected with synthetic mRNA encoding the indicated protein+ Forty-eight
hours later the oocytes were fractionated into cytoplasmic and nuclear fractions (C and N), and the localization of the
proteins determined using the mobility shift assay+ Each lane represents material from one oocyte+ Only the complexes
formed (designated xSLBP1/RNA and xSLBP2/RNA) are shown; the unbound probe is not shown in this experiment+
Lanes 1 and 2: xSLBP1; lanes 3 and 4: 1-2-1; lanes 5 and 6: xSLBP2+
Processing requires the RNA-binding domain of SLBP 1639
 on February 14, 2006 www.rnajournal.orgDownloaded from 
found exclusively in the cytoplasm (Fig+ 3C, lanes 1, 2,
5, and 6)+ The 1-2-1 protein is imported into the nu-
cleus as efficiently as the xSLBP1 (Fig+ 3C, lanes 3 and
4), indicating that its inability to enhance processing
was not a result of failure to localize to the nucleus+
The 1-2-1 chimeric protein has a similar
RNA-binding affinity to SLBP1
in oocyte extracts
One possible explanation for the failure of the 1-2-1
protein to efficiently complement processing is that it
might have a reduced affinity for the stem-loop+ We
compared the ability of xSLBP1 and the 1-2-1 protein
to bind the 39 end of histone mRNA using three differ-
ent approaches+
We compared the binding affinity of the two proteins
by expressing them from the synthetic mRNA in the
rabbit reticulocyte lysate+ To determine the amount of
each protein synthesized, the proteins were labeled
with 35S-methionine (Fig+ 4A, left panel)+ The lysates
were then tested for their ability to bind the stem-loop
using equal amounts of radiolabeled protein+ Compe-
tition experiments were done using increasing amounts
of competitor RNA (Fig+ 4A, right panel)+ The two pro-
teins bound the RNA probe to a similar extent and
showed identical patterns of competition, demonstrat-
ing that they had similar affinities for the stem-loop
RNA+
Each of the proteins was overexpressed in oocytes
to similar levels by injection of synthetic pre-mRNA+ To
demonstrate that the two proteins were expressed at
similar levels, we performed western blots using an
antibody that recognized the N and C terminal domains
of xSLBP1 (Fig+ 4B, left panel)+ At the exposure shown
in the western blot the endogenous xSLBP1 in un-
injected oocytes is barely detectable (not shown), dem-
onstrating the high level of expression relative to the
endogenous protein+ Similar amounts of SLBP–stem-
loop complex were formed in oocytes expressing
xSLBP1 (1-1-1) and 1-2-1 proteins (Fig+ 4B, right panel)+
We also compared the relative affinities of the SLBP
in extracts from oocytes expressing the same proteins+
The level of overexpression of SLBP active in RNA
binding is high in all of these experiments and is clearly
seen by comparing lanes 2 and 9 of Figure 4C with
lanes 3 and 10, consistent with the results obtained
from the western blot+ Extracts were prepared from the
oocytes and the affinity of the proteins for the stem-
loop measured by the amount of competitor RNA nec-
essary to compete formation of the stem-loop RNA
complex+ Because the concentrations of xSLBP1 and
1-2-1 are similar in the two extracts, this provides an
estimate of the relative affinities of the two proteins
under relatively physiological conditions in the pres-
ence of the total proteins from Xenopus+ Each of the
proteins also bound the stem-loop with a similar affinity
by this criterion (Fig+ 4C)+
To further demonstrate the similar affinity of 1-2-1
and xSLBP1 for the stem-loop, three proteins, myc-
tagged xSLBP1 (which is larger than xSLBP1 and can
be distinguished from 1-2-1), 1-2-1, and a 94 amino
acid protein 0-1-(1/2), were overexpressed in the same
oocyte by injecting a mixture containing equal amounts
of the three synthetic mRNAs+ When these three pro-
teins were expressed simultaneously in oocytes, three
distinct complexes were formed with the stem-loop RNA
in oocyte extracts (Fig+ 4D)+ To assess the relative af-
finity of the three proteins, mobility shift assays were
done using varying amounts of radiolabeled probe+ At
low probe concentrations, the three proteins are com-
peting for limiting probe+ At the three concentrations of
the probe used, all three proteins formed complexes
with the probe+ The complexes are present in similar
relative proportions (Fig+ 4D, lanes 1–3), indicating that
all three proteins bound the probe with similar affinity+ If
there were any slight differences in affinity, the 1-2-1
and 0-1-(1/2) proteins had a slightly higher affinity than
the myc-SLBP1 protein, because at the lowest probe
concentrations (Fig+ 4D, lanes 2 and 3), these com-
plexes were overrepresented compared with the amount
of complex formed by the full-length xSLBP1+ Using
similar approaches we have previously shown that the
full-length endogenous xSLBP1 and xSLBP2 proteins
have similar affinities for the stem-loop (Wang et al+,
1999)+
Both the 1-2-1 protein and xSLBP1 (1-1-1) form very
stable complexes with the stem-loop RNA+ When the
extracts from oocytes overexpressing these two pro-
teins were incubated with the probe for 20 min followed
by addition of excess unlabeled competitor RNA, the
unlabeled competitor did not displace the pre-bound
radiolabeled probe (Fig+ 4E, lanes 3 and 5)+ In contrast,
addition of the same amount of unlabeled probe to-
gether with the labeled probe completely prevented for-
mation of the labeled complexes (Fig+ 4E, lane 6)+ Thus,
like the mammalian SLBP (Williams & Marzluff, 1995),
the complexes between the stem-loop and the frog
SLBP (and the 1-2-1 protein), are extremely stable+ By
all of these criteria, the 1-2-1 protein and the xSLBP1
have similar affinities for the stem-loop+
The 1-2-1 protein is also inactive in histone
pre-mRNA processing in vitro
We next tested the ability of the 1-2-1 protein to func-
tion in an in vitro processing reaction+ A nuclear extract
from mouse myeloma cells efficiently processes a syn-
thetic substrate containing the histone H1t downstream
element+ Processing of this substrate is completely de-
pendent on the presence of SLBP (Dominski et al+,
1999; Fig+ 5A, lanes 1 and 3)+ The histone H1t pre-
mRNA is also processed in Xenopus oocytes as effi-
1640 T.C. Ingledue III et al.
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FIGURE 4. Relative binding affinities
of xSLBP1 and the mutant SLBPs+
A: xSLBP1 (1-1-1) and 1-2-1 were
expressed from the same synthetic
mRNAs used for microinjection in the
reticulocyte lysate in the presence of
35S-methionine+ The proteins were re-
solved on a 10% SDS-polyacrylamide
gel and detected by autoradiography
(left panel)+ Lane 3 is a control lucif-
erase mRNA+ Equal amounts of the
reticulocyte lysates were tested for the
ability to bind the stem-loop using a
mobility shift assay (lanes 1 and 6,
right panel), in the presence of increas-
ing amounts of competitor stem-loop
RNA (lanes 2–5 and 7–10, right panel)+
B: Expression of xSLBP1 (1-1-1) and
1-2-1 detected by western blotting+
Equal amounts of synthetic mRNAs
encoding xSLBP1 (1-1-1) and 1-2-1
protein were injected into oocytes+
Extracts were prepared from oocytes
after 10 h and the proteins detected
by western blotting (left panel) using
an antibody that reacts with the N- and
C-terminal regions of xSLBP1+ The
same extracts (1/60 oocyte) were
used in a mobility shift experiment
using the stem-loop as a probe (right
panel)+ C: xSLBP1 (1-1-1) (lanes 3–7)
and 1-2-1 (lanes 10–14) were over-
expressed in stage VI Xenopus oo-
cytes+ Extracts from these oocytes
were incubated with radiolabeled
probe and increasing amounts of un-
labeled stem-loop RNA+ Complexes
(xSLBP2/RNA and xSLBP1/RNA)
were resolved by nondenaturing gel
electrophoresis+ Lanes 2 and 9 show
the endogenous levels of xSLBP1 and
xSLBP2+ Lanes 1 and 8 show the
probe+D:A myc-tagged xSLBP1 (myc-
xSLBP1), 1-2-1, and 0-1-(1/2) were
coexpressed in Xenopus oocytes by
injection of a mixture of the three syn-
thetic mRNAs+ An extract from these
oocytes was incubated with decreas-
ing amounts of radiolabeled stem-loop
RNA+ The complexes were resolved
by gel electrophoresis+ E: xSLBP1
(1-1-1) (lanes 2 and 3) and 1-2-1
(lanes 4–6) were overexpressed in
stage VI Xenopus oocytes+Oocyte ex-
tracts were incubated with the radio-
labeled probe (lanes 2 and 4) or
preincubated for 15 min with the probe
before addition of a 1,000-fold excess
of cold competitor (lanes 3 and 5) be-
fore analysis of the complexes by gel
electrophoresis+ In lane 6, the same
amount of competitor was mixed with
the probe and added+ Lane 1 is the
probe+
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ciently as the H2a-614 pre-mRNA (data not shown)+
The mouse SLBP was removed from the extract using
an antibody against the C-terminus of the protein (Wang
et al+, 1996c), abolishing processing of this histone pre-
mRNA substrate (Dominski et al+, 1999; Fig+ 5A, lane 3)+
The depleted extract was complemented with various
recombinant SLBPs expressed in baculovirus+Addition
of the recombinant human SLBP expressed and puri-
fied from baculovirus restored processing to control lev-
els (Fig+ 5A, lane 4)+ Addition of the xSLBP1 protein
also restored processing, whereas the xSLBP2 protein
was inactive (Fig+ 5A, lanes 5, 6; Wang et al+, 1999)+
The chimeric protein 1-2-1 bound the stem-loop effi-
ciently (Fig+ 5C, lane 3), but was not able to com-
plement processing in vitro (Fig+ 5B, lane 4), clearly
demonstrating a role for the RBD in the processing
reaction in addition to its ability to bind the pre-mRNA+
Consistent with our results with mammalian SLBP (Dom-
inski et al+, 1999), the 2-1-1 chimeric protein comple-
mented processing (Fig+ 5B, lane 5), whereas the 1-1-2
protein had very little activity (Fig+ 5B, lane 6)+ This
suggests that there is a requirement for the C-terminal
domain as well as the RBD of xSLBP1 in processing+
Because the 1-2-1 protein binds the histone pre-
mRNA with the same affinity as xSLBP1, we tested the
ability of this protein to compete with mouse SLBP in
the processing reaction in the nuclear extract+ The nu-
clear extract processed about 70% of the synthetic his-
tone H2a-614 pre-mRNA in 30 min (Fig+ 6A, lanes 1
and 4)+ Addition of human SLBP to the extract in-
creased the processing efficiency to .90% (Fig+ 6A,
lanes 2 and 5) whereas addition of the same amount of
recombinant xSLBP2 reduced the processing efficiency
to ,10% (Fig+ 6A, lane 3)+ A similar inhibition of pro-
FIGURE 5. Complementation of processing of histone mRNA in vitro with chimeric proteins+ A: A nuclear extract active in
histone pre-mRNA processing was prepared from mouse myeloma cells (lane 1)+ Removal of the mouse SLBP from the
extract using an antibody to its C-terminus abolished processing (lane 3), whereas depletion with IgG from preimmune
serum had little effect on the activity (lane 2)+ The extract was supplemented with 20 ng of human SLBP (lane 4), frog
xSLBP1 (lane 5), or frog xSLBP2 (lane 6)+ A radiolabeled synthetic histone pre-mRNA was added to the extract, incubated
for 60 min at 32 8C and RNA prepared+ The RNAs were resolved by gel electrophoresis and detected by autoradiography+
The processed (Proc) and unprocessed (Unproc) mRNAs are indicated+ B: The depleted extract (lane 2) was supplemented
with 20 ng of the indicated recombinant proteins expressed in baculovirus (lanes 3–6)+ hSLBP is human SLBP+ The
processing reaction was carried out as in A+ Lane 1 is undepleted nuclear extract+ C: Twenty nanograms of the recombinant
proteins 2-1-1 or 1-2-1 were incubated with the radiolabeled stem-loop and the complexes resolved by native gel electro-
phoresis+ Lane 1 shows the free probe+
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cessing was obtained by addition of the 1-2-1 protein
(Fig+ 6A, lane 6)+ Thus recombinant proteins containing
the xSLBP2 RNA binding domain compete for binding
to the pre-mRNA substrate and act as dominant-
negative proteins in the processing reaction+
Different requirements for processing of
injected histone pre-mRNA and in
vivo-transcribed histone pre-mRNA
in Xenopus oocytes
Strikingly, the overexpressed 1-2-1 protein did not block
the processing of histone pre-mRNA by the endog-
enous xSLBP1 (Fig+ 3A, lane 5; Fig+ 3B, lane 4), al-
though the 1-2-1 protein was localized to the nucleus
and was overexpressed at least 10-fold relative to the
endogenous SLBP1 (Fig+ 4)+ It was not a dominant-
negative protein for processing pre-mRNA transcribed
from a histone gene in vivo, although it acted as a
dominant-negative protein in vitro+
One difference in these two systems is that in vivo
the histone pre-mRNA was produced by transcription
from an injected gene+ It is possible that there was
preferential recruitment of xSLBP1 to the histone pre-
mRNA during transcription+We reasoned that injection
of histone pre-mRNA (rather than histone genes) into
Xenopus oocyte nuclei,might reveal different effects of
the 1-2-1 protein on histone pre-mRNA processing, be-
cause, in that case, both the exogenously expressed
and the endogenous proteins might have similar ac-
FIGURE 6. Processing of injected synthetic pre-mRNA in Xenopus oocytes+ A: A nuclear extract prepared from mouse
myeloma cells was incubated with the radiolabeled H1t pre-mRNA for 30 min (lanes 1 and 4)+ Seventy-five nanograms of
human SLBP (lanes 2 and 5), xSLBP2 (lane 3), or 1-2-1 protein (lane 6) was added to the extract prior to addition of the
H1t pre-mRNA+ The RNA was resolved by gel electrophoresis and detected by autoradiography+ B: Histone H2a-614
pre-mRNA together with blue Dextran was injected into the nucleus (lane 2) or the cytoplasm (lane 3) of Xenopus oocytes+
RNA was prepared after 2 h and assayed as described in Figure 1+ Lane 1 is marker pUC18 digested with MspI+ C: Two
separate batches of frog oocytes were injected with buffer or with synthetic mRNA encoding either the 1-2-1 protein (lanes 2
and 5) or the full-length xSLBP1 (lanes 3 and 6) and incubated for 30 h+ They were then injected in the nucleus with synthetic
H2a-614 pre-mRNA plus blue Dextran+ Two hours later RNA was prepared and analyzed as in B+ D: The same batch of
ooctyes as in C, lanes 1–3, were injected with the indicated synthetic mRNAs and incubated for 30 h, and then injected with
the H2a-614 gene and blue Dextran in the nucleus+ Eighteen hours later RNA was prepared and analyzed as in B+ Lane M
is marker pUC18 digested with MspI+
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cess to the pre-mRNA in the nucleoplasm+ Cleavage of
a synthetic histone pre-mRNA injected into Xenopus
oocyte nuclei was one of the initial lines of evidence for
formation of the 39 end of histone mRNA by an RNA
processing reaction (Krieg & Melton, 1984)+
A synthetic histone H2a-614 pre-mRNA identical in
sequence to the pre-mRNA synthesized from the his-
tone gene was injected into Xenopus oocyte nuclei
or cytoplasm+ The histone pre-mRNA injected into the
nucleus was processed with about 60% efficiency in
this experiment (Fig+ 6B, lane 2), whereas the his-
tone pre-mRNA injected into the cytoplasm was not
processed, but was stable (Fig+ 6B, lane 3)+ We in-
jected about 10% as much histone pre-mRNA as was
synthesized from the injected histone genes in 18 h
and assayed processing after a 2-h incubation+ Thus
the concentration of histone pre-mRNA in the nu-
cleus in the RNA injection and the histone gene in-
jection experiments are likely to be similar+ As with
the histone gene injections, the efficiency of process-
ing of the injected histone pre-mRNA varied between
batches of oocytes+
To see whether there was a difference in the ability
to affect processing on the same substrate intro-
duced into nuclei by two different methods, oocytes
were injected with synthetic mRNAs encoding the
xSLBP1 and 1-2-1 proteins+ They were subsequently
injected in the nucleus with either the histone H2a-
614 gene or with the synthetic histone H2a-614 mRNA+
Because any histone pre-mRNA injected into the cy-
toplasm will not be processed (Stefanovic et al+, 1995;
Fig+ 6B, lane 3), only oocytes that had been success-
fully injected in the nucleus, as determined by coinjec-
tion of blue Dextran, were analyzed+ Overexpression
of full-length xSLBP1 stimulated processing in the
DNA-injected oocytes as shown previously (Fig+ 6D,
lane 4) and had a smaller stimulatory effect in the
RNA-injected oocytes (Fig+ 6C, lanes 3 and 6)+ In
contrast overexpression of the 1-2-1 protein had little
effect on processing of the in vivo generated histone
pre-mRNAs (Fig+ 6D, lane 3) consistent with the re-
sults shown previously in Figure 3+ However, expres-
sion of the 1-2-1 protein inhibited processing about
80% in oocytes injected with the histone pre-mRNA
(Fig+ 6C, lanes 2 and 5)+
The 1-2-1 protein can block processing, presum-
ably by binding to the histone pre-mRNA in a non-
productive complex, in the nuclear extract and in
oocytes into which histone pre-mRNA has been in-
jected into the nucleoplasm of the germinal vesicle+
In contrast, the histone pre-mRNA expressed from
the histone DNA in oocytes is insensitive to the pres-
ence of the 1-2-1 protein, suggesting that xSLBP1
(and not the chimeric protein 1-2-1) is preferentially
recruited to the site of histone gene transcription, where
it then stimulates processing of histone mRNA tran-
scribed from the injected gene+
DISCUSSION
The only processing event required for formation of
histone mRNA is cleavage of the nascent transcript to
form the 39 end of histone mRNA+ In the cell, this re-
action probably also serves to release the nascent RNA
from the chromatin template+ Processing of histone pre-
mRNA requires assembly of both SLBP and U7 snRNP
on the pre-mRNA (Dominski et al+, 1999)+ Increased
expression of either of these factors in frog oocytes
stimulates processing of histone pre-mRNA transcribed
from an injected gene (Fig+ 1D; Jacobs et al+, 1999;
Wang et al+, 1999)+We have previously shown that the
two Xenopus SLBPs have different functions+ xSLBP1
is orthologous to human and mouse SLBP and partici-
pates in histone mRNA 39 end formation (Wang et al+,
1999)+ xSLBP2 is expressed only during oogenesis, is
degraded after oocyte maturation (Wang et al+, 1999),
and may be involved in storing maternal histone mRNA
in a translationally inactive form+
The xSLBP1 RNA binding domain
has multiple functions
Both xSLBP1 and xSLBP2 bind to the same cis-acting
sequence with similar affinity, and contain similar RBD
(Wang et al+, 1999)+ Substitution of the RBD of xSLBP2
into xSLBP1 resulted in a protein, 1-2-1, that differs
from xSLBP1 in only 22 of the 73 amino acids in the
RBD+ Surprisingly, this protein is totally inactive in pro-
cessing both in vivo and in vitro even though it retains
the ability to bind RNA+ This result demonstrates that
xSLBP1 does not contain distinct RNA-binding and
-processing domains, unlike transcription factors,many
of which have structurally distinct DNA-binding and tran-
scription activation domains that are often interchange-
able+ Instead, specific sequences in the RBD of xSLBP1
are critical for processing, although they are not re-
quired for RNA binding+ Specific amino acids in the
RBD of xSLBP1 probably interact directly with other
components of the processing machinery, possibly as-
sisting the SLBP in stabilizing the binding of U7 snRNP
to the histone pre-mRNA (Dominski et al+, 1999)+ Inter-
actions between the RBD of xSLBP1 and the U7 snRNP
could help explain the strict dependence of processing
on the distance between the stem-loop and the U7
snRNP binding site (Scharl & Steitz, 1994; Cho et al+,
1995)+
It is formally possible that the RBD of xSLBP2 con-
tains a sequence that actively inhibits processing+ If
this were the case, then the sequences in the RBD of
xSLBP1 would not actively participate in the process-
ing reactions+We think this possibility is unlikely for two
reasons+ First, the 1-2-1 protein is not active in a mam-
malian extract+Mammals do not contain an SLBP2 and
hence would not be expected to contain a putative in-
hibitor+ Second, we have recently cloned the Drosoph-
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ila SLBP, and constructed a similar hybrid protein in
which the Drosophila RBD replaces the mammalian
RBD (E+ Sullivan and W+F+ Marzluff, unpubl+ results)+
This hybrid protein, 1-D-1, binds the stem-loop with
high affinity and is also inactive in processing in both a
mammalian extract and in frog oocytes (T+C+ Ingledue,
Z+ Dominski, and E+ Sullivan, unpubl+) although there is
only one SLBP in Drosophila and this protein partici-
pates in histone pre-mRNA processing in Drosophila+
These results strongly argue for a positive role of the
RBD of xSLBP1 in histone pre-mRNA processing+
Different effects of the 1-2-1 protein on
processing of histone pre-mRNA transcribed
in the nucleus and histone pre-mRNA
injected into the nucleus
One might expect that proteins that bind to the pre-
mRNA but are not capable of processing would have a
dominant-negative effect on the processing reaction,
particularly when they are present in excess+ This is
true for both xSLBP2 and 1-2-1 when they were added
to a nuclear extract+ xSLBP2 is present exclusively in
the cytoplasm (Wang et al+, 1999), and so would not be
able to affect histone pre-mRNA processing in vivo+
However, the 1-2-1 protein is imported into the nucleus
as efficiently as the xSLBP1 (Fig+ 3C)+ When the 1-2-1
protein was expressed in large (.20-fold) excess over
the endogenous xSLBP1, there was little effect on pro-
cessing of histone pre-mRNA expressed from a his-
tone gene, even though much of the 1-2-1 protein was
present in the nucleus+ In contrast, the overexpressed
1-2-1 inhibited processing of the injected histone pre-
mRNA, although it had little effect on the processing of
the same pre-mRNA generated in the oocyte nucleus+
The failure of the overexpressed 1-2-1 protein to sig-
nificantly affect the processing of the in vivo-synthesized
pre-mRNA, suggests that the smaller amount of xSLBP1
(relative to 1-2-1) in the nucleus is preferentially re-
cruited to the site of gene mRNA transcription, whereas
the abundant 1-2-1 protein in the nucleus clearly does
not have access to the histone pre-mRNA transcribed
from the injected gene+A specific sequence in the RBD
must be part of this selective recruitment mechanism+
In contrast, when the histone pre-mRNA is injected into
the nucleus, the 1-2-1 protein can then compete with
the xSLBP1 for binding to the protein, as it can in the in
vitro system+
In the cell, much of the U7 snRNP is found in Cajal
(coiled) bodies, “spheres” in Xenopus oocytes (Wu &
Gall, 1993; Wu et al+, 1996), and these nuclear organ-
elles are located near the histone genes in oocytes
(Callan et al+, 1991) and in mammalian cells (Frey &
Matera, 1995; Matera, 1999), suggesting a role for the
coiled bodies in histone pre-mRNA processing+ Some
of the xSLBP1 in the frog oocyte is also located in the
spheres (Abbott et al+, 1999)+ One possibility is that
xSLBP1 may function in a distinct subnuclear compart-
ment+ The histone genes have remained tightly clus-
tered throughout evolution, suggesting that there is
selective pressure keeping them closely linked (Wang
et al+, 1996a, 1996b)+ One reason for this tight cluster-
ing may be that the genes are localized in a region of
the nucleus specific for histone mRNA processing+
Ninety-five percent of the U7 snRNA in the Xenopus
oocyte nucleus is present in spheres (Wu & Gall, 1993)+
Spheres are found dispersed in the nucleoplasm and
some are physically attached to the chromosomes at
histone gene loci in amphibian oocyte lampbrush chro-
mosome spreads (Callan et al+, 1991)+Recently Gall and
coworkers have shown that xSLBP1 is present in the
spheres of the amphibian germinal vesicle (Abbott et al+,
1999)+Aregion of xSLBP1, including part of the RBD and
the C-terminal region, is capable of directing the xSLBP1
to coiled bodies (Abbott et al+, 1999)+ The spheres also
contain RNA polymerase II and coilin (Bellini & Gall,
1998),which has also been shown to associate with the
U7 snRNP (Bellini & Gall, 1998)+
Localization of xSLBP1 to the spheres (coiled bod-
ies) may be important for efficient histone pre-mRNA
processing in vivo+ The 1-2-1 protein may be defi-
cient in localizing to the coiled bodies or may not
interact with unknown factor(s) necessary for process-
ing in vivo, but not in vitro+ In nuclear extracts, any
nuclear substructures are disrupted allowing inter-
action of factors that may be physically separated in
the nucleus in vivo+ It is also likely that histone pre-
mRNA processing is coupled to histone gene tran-
scription in vivo, as is polyadenylation (McCracken
et al+, 1997)+ Thus in vivo there may be a defined
pathway by which the histone pre-mRNA processing
machinery is assembled and this pathway could be
disrupted in nuclear extracts+
Differences in metabolism of the same RNA mol-
ecule transcribed from a gene and injected into the
nucleoplasm are likely to be observed in many cases+
Differences in the “masking” of mRNAs have been
observed in Xenopus oocytes depending on whether
synthetic pre-mRNA was injected or whether the pre-
mRNA was expressed from an injected gene (Meric
et al+, 1996; Matsumoto et al+, 1998)+ It is likely that
many steps in nuclear RNA metabolism are tightly cou-
pled in vivo, and can only be accurately reproduced
starting with RNAs transcribed from the appropriate
gene+
The histone genes represent a distinct class of genes
transcribed by RNA polymerase II, and it is likely that
there are novel pathways, distinct from those involved
in metabolism of polyadenylated mRNAs, for histone
mRNA metabolism+ SLBP plays a central role in all
aspects of histone mRNA metabolism and may interact
with numerous potential binding partners, both in the
nucleus and the cytoplasm+
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MATERIALS AND METHODS
Subcloning of xSLBP1 and xSLBP2 and
construction of chimeric proteins
PCR was used to amplify xSLBP1 and xSLBP2 cDNAs from
the two-hybrid vector pGAD10, removing the 59 and 39 UTRs
and inserting an NcoI site (xSLBP1) or BspH1 site (xSLBP2)
at the initiation codon+ The PCR products were digested with
either NcoI/XbaI or BspHI/XbaI and subcloned into a modi-
fied p64T vector digested with NcoI or BspHI and XbaI, which
provides 59 and 39 b-globin UTRs and a poly(A) tail for effi-
cient translation of in vitro-transcribed RNA in oocytes (Wang
et al+, 1999)+ PCR was used to insert a KpnI site at the 59 end
of the RBD of both xSLBP1 and xSLBP2, and a BamH1 site
into the 39 end of the RBD of xSLBP2+ There was a preexist-
ing BamH1 site at the 39 end of the RBD of xSLBP1+ The
chimeric clones were then made by combining the fragments
from the N-terminal domain (NcoI-KpnI), the RBD (KpnI-
BamH1), and the C-terminal (BamH1-XbaI) domain+ The se-
quence of all clones was confirmed at the University of North
Carolina, Chapel Hill sequencing facility+ The 0-1-1/2 clone
was constructed by cloning the 100 amino acid fragment of
SLBP1 into the same vector using PCR and introducing an
NcoI site to provide an initiation codon at the beginning of the
RBD+
Synthesis of mRNA and injection
into Xenopus oocytes
The plasmids were linearized with EcoRI and used to make
capped RNA with SP6 RNA polymerase (Wang et al+, 1999)+
Ovaries were removed from female frogs and treated with
0+2% collagenase in OR-2 for 2 h (Kay, 1991)+ They were
rinsed profusely with OR-2 and stored in OR-2 overnight for
recovery+Healthy stage V-VI oocytes were injected with 45 nL
of a solution containing 0+5 mg/mL of the in vitro-synthesized
capped RNA encoding the SLBP constructs+ The oocytes
were incubated for 48 h at 18 8C in OR-2+ RNA was prepared
from pools of 30 oocytes for each point+
Histone pre-mRNA processing in oocytes
Forty-eight hours after the injection of the synthetic mRNA
encoding SLBP proteins, healthy oocytes were then injected
in the nucleus with 15 nL of mouse H2a-614 DNA, 0+03 mg/mL
(450 pg), and incubated for 18 h in OR-2 prior to preparation
of the RNA from pools of 30 oocytes for each point+ For
experiments with human U7 snRNA, 450 pg of a plasmid
containing the human U7 gene was coinjected with the mouse
H2a-614 gene (Jacobs et al+, 1999)+
The transcription inhibitor Actinomycin D (Sigma) was used
at 200 mg/mL in the media to completely block transcription
(Longo et al+, 1996)+ Actinomycin D was dissolved in ethanol
and the final concentration of ethanol in the media was less
than 0+5%+ Oocytes were treated with Actinomycin D for 1 h
prior to H2a-614 gene injection and maintained in inhibitor in
the dark+ For the chase experiment, oocytes were injected
with the H2a-614 gene, allowed to transcribe RNA for 18 h
and subsequently incubated with Actinomycin D for 5 h in the
dark before preparation of RNA+
Processing of synthetic pre-mRNA in oocytes
The mouse histone H2a-614 gene was amplified using PCR
and oligonucleotides, with the 59 oligonucleotide containing a
T7 RNA polymerase promoter+ A synthetic 640-nt capped
pre-mRNA that contained the histone 39 processing signal
was synthesized as described above using T7 RNA polymer-
ase+ The pre-mRNA contained the entire H2a-614 mRNA and
extended 100 nt past the 39 end of the histone mRNA+ Eight
hundred picograms of the pre-mRNA were injected into the
oocyte nucleus (together with blue Dextran to identify those
oocytes that had been successfully injected in the nucleus)+
Two hours after injection of the synthetic pre-mRNA, the oo-
cytes with blue nuclei were harvested+ RNA was prepared
from pools of 30 oocytes and the amount of processed his-
tone mRNA was measured using an S1 nuclease protection
assay described below+
RNA extraction and analysis
Oocytes (30 oocytes were pooled for each sample) were
homogenized in 300 mM NaCl, 50 mM Tris, 10 mM EDTA,
2% SDS, and 5 mg/mL Proteinase K (Boehringer-Mannheim)
and incubated for 1 h at 37 8C+ The homogenate was ex-
tracted with water-saturated phenol/chloroform and then with
chloroform+ The RNA was precipitated from the aqueous
phase by addition of 1/10 vol of 3 M NaOAC and 0+6 vol of
isopropanol+
An oocyte equivalent of RNA was used to perform S1
nuclease analysis+ A Pst I/HpaII fragment of the mouse H2a-
614 gene, extending from amino acid 85 in the coding region
to 34 nt past the 39 end of histone mRNA, was cloned into the
Pst I/ClaI sites of BlueScript II SK (Stratagene) to generate
pSL3+ A 260-nt fragment was amplified by PCR from pSL3
using an oligonucleotide complementary to the T7 promoter
and an oligonucleotide (59-GCTGCTGGGCAAAGTGAC-39)
complementary to the coding region of the mouse H2a-614
gene+ This fragment ends in a 39 deoxycytidine followed by a
random, terminal 39 unpaired nucleotide from the PCR reac-
tion+ The PCR fragment was 39-end labeled with the Klenow
fragment of DNA polymerase I (New England Biolabs) and
[a-32P]-dCTP, using the 39 exonuclease activity to exchange
the terminal paired deoxycytidine+ Ten nanograms of probe
were hybridized with an oocyte-equivalent of RNA+ The con-
ditions of hybridization and digestion have been previously
described (Wang et al+, 1999)+ The protected fragments were
resolved on a 7+5% polyacrylamide-7 M urea gel, detected by
autoradiography and quantified on a PhosphorImager (Mo-
lecular Dynamics)+ Properly processed RNA protected a frag-
ment of 183 nt and unprocessed RNA protected a fragment
of 217 nt, extending to the region of divergence between the
probe and the injected gene+
Mobility shift assays
Mobility shift assays were performed using a 30-nt synthetic
RNA as a probe essentially as previously described (Williams
& Marzluff, 1995)+ Oocyte extracts were prepared and ex-
tracted with freon to remove the yolk+ For the nuclear local-
ization experiments, oocytes were fractionated into nucleus
and cytoplasm as previously described and the overexpressed
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SLBPs detected by mobility shift assays (Wang et al+, 1999)+
Competition experiments were done as previously described
(Williams & Marzluff, 1995)+
Baculovirus protein production
The chimeric and deletion constructs were subcloned into the
baculovirus pFastBacHTb (Gibco BRL)+ SF9 cells were in-
fected with the baculovirus for 96 h and the recombinant
proteins purified on nickel affinity columns (Dominski et al+,
1999)+ The proteins were checked for purity by SDS-gel elec-
trophoresis and for RNA binding activity in a gel shift assay
(Williams & Marzluff, 1995)+
Complementation of histone pre-mRNA
processing with baculovirus
expressed proteins
A nuclear extract active in histone pre-mRNA processing was
prepared from mouse myeloma cells as previously described
(Dominski et al+, 1995; Marzluff et al+, 1997)+ SLBP was re-
moved from this extract by incubation with SLBP antibody
followed by removal of the antibody-SLBP complex by pro-
tein A agarose (Wang et al+, 1996c, 1999; Dominski et al+,
1999)+ The purified SLBPs expressed in baculovirus (20 ng)
were added to the extract+ A radiolabeled synthetic 86 nt
RNA, including a stem-loop and the U7 binding site from the
mouse histone H1t gene (Dominski et al+, 1999), was incu-
bated in this extract for 60 min at 32 8C+ The RNA was purified
and analyzed by polyacrylamide gel electrophoresis and the
products detected by autoradiography+
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